{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:02:52Z","timestamp":1788498172289,"version":"build-2803163510"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302624, 81873909"],"award-info":[{"award-number":["81302624, 81873909"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2020.00312","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:43:48Z","timestamp":1587429828000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["No Impact of Omega-3 Fatty Acid Supplementation on Symptoms or Hostility Among Patients With Schizophrenia"],"prefix":"10.3389","volume":"11","author":[{"given":"Yi","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Qin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng Ju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","article-title":"The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia","volume":"30","author":"Horrobin","year":"1998","journal-title":"Schizophr Res"},{"key":"B2","first-page":"19","article-title":"Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia","volume":"45","author":"Peet","year":"2008","journal-title":"Israel J Psychiatry Related Sci"},{"key":"B3","first-page":"193","article-title":"Abnormalities of fatty acid metabolism in red cells, platelets and brain in schizophrenia","volume-title":"Phospholipid Spectrum Disorders in Psychiatry and Neurology","author":"Yao","year":"2003"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.192","article-title":"Long-chain \u03c9-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial","volume":"67","author":"Amminger","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2003.08.008","article-title":"From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia","volume":"69","author":"Skosnik","year":"2003","journal-title":"Prostaglandins Leukotrienes Essential Fatty Acids"},{"key":"B6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/npp.2011.187","article-title":"Update on omega-3 polyunsaturated fatty acids in early-stage psychotic disorders","volume":"37","author":"Amminger","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1038\/sj.npp.1301628","article-title":"Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study","volume":"33","author":"Berger","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2006.01.021","article-title":"Docosahexaenoic acid promotes neurogenesis in vitro and in vivo","volume":"139","author":"Kawakita","year":"2006","journal-title":"Neuroscience"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00933.2005","article-title":"Docosahexaenoic acid induces ciap1 mRNA and protects human endothelial cells from stress-induced apoptosis","volume":"290","author":"Pfrommer","year":"2006","journal-title":"Am J Physiology-Heart Circulatory Physiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2012.08.002","article-title":"Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia","volume":"141","author":"Gama","year":"2012","journal-title":"Schizophr Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1206","article-title":"Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial","volume":"68","author":"Berger","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.9.1596","article-title":"Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia","volume":"159","author":"Emsley","year":"2002","journal-title":"Am J Psychiatry"},{"key":"B13","article-title":"A meta-analysis of placebo-controlled trials of omega-3 fatty acid augmentation in schizophrenia: Possible stage-specific effects","volume":"27","author":"Chen","year":"2015","journal-title":"Ann Clin Psychiatry : Off J  Am Acad Clin Psychiatrists"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.3.477","article-title":"Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder","volume":"159","author":"Nemets","year":"2002","journal-title":"Am J Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs","volume":"59","author":"Peet","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.1.167","article-title":"Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study","volume":"160","author":"Zanarini","year":"2003","journal-title":"Am J Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.181.1.22","article-title":"Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners","volume":"181","author":"Gesch","year":"2002","journal-title":"Br J Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2007.09.005","article-title":"Psychiatric diagnosis and aggression before acute hospitalisation","volume":"23","author":"Colasanti","year":"2008","journal-title":"Eur Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2014.06.012","article-title":"Low plasma eicosapentaenoic acid levels are associated with elevated trait aggression and impulsivity in major depressive disorder with a history of comorbid substance use disorder","volume":"57","author":"Beier","year":"2014","journal-title":"J Psychiatr Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnim.2014.10.022","article-title":"Baseline omega-3 index correlates with aggressive and attention deficit behaviours in adult prisoners","volume":"1","author":"Meyer","year":"2014","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cbm.1954","article-title":"Relationships of diet-related blood parameters and blood lead levels with psychopathology and aggression in forensic psychiatric inpatients","volume":"26","author":"Zaalberg","year":"2015","journal-title":"Criminal Behav Ment Health"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/ab.20335","article-title":"Effects of nutritional supplements on aggression, rule-breaking, and psychopathology among young adult prisoners","volume":"36","author":"Zaalberg","year":"2010","journal-title":"Aggressive Behav"},{"key":"B23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1192\/S0007125000291514","article-title":"The positive and negative syndrome scale (PANSS): rationale and standardisation","volume":"155","author":"Kay","year":"1989","journal-title":"Br J Psychiatry Suppl"},{"key":"B24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/sj.ejcn.1601739","article-title":"Hibbeln JJEJoCN. Dietary intake of n-3, n-6 fatty acids and fish: relationship with hostility in young adults\u2014the CARDIA study","volume":"58","author":"Iribarren","year":"2004","journal-title":"Eur J Clin Nutr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2010.02.016","article-title":"Hostility of drug-free patients with schizophrenia and n\u2013 3 polyunsaturated fatty acid levels in red blood cells","volume":"177","author":"Watari","year":"2010","journal-title":"Psychiatry Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/BF02911031","article-title":"The reliability, validity of PANSS and its implication","volume":"18","author":"Tianmei","year":"1992","journal-title":"Chin Ment Health J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3109\/1365150090305653","article-title":"The reliability and validity of the Chinese version of the Modified Overt Aggression Scale","volume":"13","author":"Huang","year":"2009","journal-title":"Int J Psychiatry Clin Pract"},{"key":"B28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1177\/009318539202000211","article-title":"The impact of clozapine on 25 forensic patients","volume":"20","author":"Maier","year":"1992","journal-title":"Bull  Am Acad Psychiatry  Law"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000117424.05703.29","article-title":"Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol","volume":"24","author":"Volavka","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.03.023","article-title":"The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial","volume":"84","author":"Emsley","year":"2006","journal-title":"Schizophr Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.2071","article-title":"A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia","volume":"158","author":"Fenton","year":"2001","journal-title":"Am J Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0022-3956(01)00048-6","article-title":"A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms","volume":"36","author":"Peet","year":"2002","journal-title":"J Psychiatr Res"},{"key":"B33","article-title":"Ethyl-eicosapentaenoic acid (E-EPA) supplementation in early psychosis. A double blind randomized placebo-controlled add on study in 80 drug-naive first episode psychosis patients","volume-title":"International Journal of Neuropsychopharmacology","author":"Berger","year":"2004"},{"key":"B34","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.schres.2007.05.023","article-title":"Omega-3 and violence in schizophrenia","volume":"96","author":"L\u00e9gar\u00e9","year":"2007","journal-title":"Schizophr Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.12","article-title":"The relationship between delusions and violence: findings from the East London first episode psychosis study","volume":"70","author":"Coid","year":"2013","journal-title":"JAMA Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00312\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:43:51Z","timestamp":1587429831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpsyt.2020.00312\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":35,"alternative-id":["10.3389\/fpsyt.2020.00312"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2020.00312","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,21]]},"article-number":"312"}}